Patients with breast cancer who developed anemia during chemotherapy had nearly three times the risk of local recurrence as those who did not, according to a new study. Anemia occurred in 18.2 percent of patients who received CMF chemotherapy.
Patients with breast cancer who developed anemia during chemotherapy had nearly three times the risk of local recurrence as those who did not, according to a new study. Anemia occurred in 18.2 percent of patients who received CMF chemotherapy.